Clinical Trials · NCT00245479
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 802
- Start date
- Apr 2002
- Locations
- 1 site, France
- Primary endpoint
- To evaluate the overall response to desmopressin treatment among previously untreated enuretic children aged 5-15 years after 3 and 6 months of treatment